Abbvie - Yahoo Search Results

- AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth
  Zacks via Yahoo Finance· 10 hours ago
  The market expects AbbVie (ABBV) to deliver a year-over-year increase in earnings on higher revenues...
- AbbVie's (ABBV) Skyrizi Gets FDA Nod for Psoriatic Arthritis
  Zacks via Yahoo Finance· 3 days ago
  AbbVie, Inc. ABBV announced that the FDA approved a second indication for its inflammatory drug,...
- Top Analyst Reports for AbbVie, Edwards Lifesciences & Johnson Controls
  Zacks via Yahoo Finance· 7 hours ago
  Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc....
- 2 Reasons to Buy AbbVie Stock, and 1 Reason to Sell
  Motley Fool· 14 hours ago
  With 2021 net revenue estimated at $56.2 billion, AbbVie (NYSE: ABBV) is one of the world's most successful pharmaceutical companies. To address this...
- Is AbbVie Stock a Top Pick for 2022?
  Motley Fool· 4 days ago
  In the case of AbbVie (NYSE: ABBV), look no further. The company is making record revenue, and the dividend is safe and growing. In fact, a biosimilar...
- Moody Lynn & Lieberson, Llc Buys AbbVie Inc, Pfizer Inc, Northrop Grumman Corp, Sells ...
  GuruFocus.com via Yahoo Finance· 12 hours ago
  Investment company Moody Lynn & Lieberson, Llc (Current Portfolio) buys AbbVie Inc, Pfizer Inc, Northrop Grumman Corp, PepsiCo Inc, American International Group Inc, sells ...
- AbbVie (ABBV) Gains But Lags Market: What You Should Know
  Zacks via Yahoo Finance· 2 days ago
  AbbVie (ABBV) closed the most recent trading day at $132.16, moving +0.14% from the previous trading...
- What This FDA News Could Mean for AbbVie's Stock
  Motley Fool· 3 days ago
  Earlier this month, AbbVie (NYSE: ABBV) completed its application to the U.S. Food and Drug Administration (FDA) for Rinvoq to treat adults with a back...
- Kercheville Advisors, LLC Buys The Carlyle Group Inc, Hess Midstream LP, Consumer Staples ...
  GuruFocus.com via Yahoo Finance· 8 hours ago
  ...Advisors, LLC (Current Portfolio) buys The Carlyle Group Inc, Hess Midstream LP, Consumer Staples Select Sector SPDR, AbbVie Inc, Hess Corp, sells DraftKings Inc, AT&T Inc, Generac Holdings Inc, Verizon Communications Inc, FAST Acquisition Corp...
- AbbVie to Face Humira Competition From Biosimilars. Here’s What Could Happen.
  Barrons.com· 3 days ago
  Next January, Amgen (ticker: AMGN) is likely to launch the first biosimilar in the U.S. to compete...